Furthermore, considering the mitogenic nature of IGF-1, its interaction with receptors can be regulated by IGFBP-3, and upregulation of IGF-1/IGFBP-3 or a lower level of IGFBP-3 may increase the risk of cancer [172, 185]. This evidence concerns the gene IGFBP3 and cancer.